DEPROMP Trial: the additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men-study protocol for a randomized trial.
Philipp KrausewitzR A BundschuhF C GaertnerM EsslerU AttenbergerJ LuetkensG KristiansenM MudersC-H OhlmannS HauserJ EllingerM RitterPublished in: Trials (2023)
German Clinical Study Register DRKS 00024134. Registered on 26 January 2021.